Home > Boards > US Listed > Biotechs > KemPharm Inc. (KMPH)

Your logic might have worked before the shelf offering...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
gi197845 Member Profile
 
Followed By 4
Posts 2,661
Boards Moderated 1
Alias Born 08/16/16
160x600 placeholder
AZSTARYS®, An Innovative ADHD Treatment Developed by KemPharm, to be Featured in a Poster Presentation at the 2021 Psych Congress GlobeNewswire Inc. - 10/27/2021 7:30:00 AM
KemPharm Announces Research Involving AZSTARYS® and Serdexmethylphenidate to be Featured in Poster Presentations at Multiple Medical Conferences during ADHD Awareness Month (October) GlobeNewswire Inc. - 10/20/2021 7:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/19/2021 9:28:21 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/19/2021 9:24:49 AM
KemPharm, Inc. Announces Uplisting to The Nasdaq Global Select Market GlobeNewswire Inc. - 10/19/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/29/2021 4:11:46 PM
KemPharm to Present at the Benzinga Healthcare Small Cap Conference GlobeNewswire Inc. - 9/27/2021 7:30:00 AM
KemPharm to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference GlobeNewswire Inc. - 9/23/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/20/2021 5:03:46 PM
KemPharm to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/1/2021 4:04:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2021 5:10:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2021 4:52:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2021 4:49:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2021 4:28:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2021 4:27:00 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/20/2021 5:05:31 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/18/2021 5:38:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/18/2021 5:02:31 PM
KemPharm Appoints Tamara A. Seymour to Board of Directors GlobeNewswire Inc. - 8/18/2021 4:45:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2021 5:02:50 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/13/2021 7:40:21 AM
KemPharm Reports Second Quarter 2021 Financial Results GlobeNewswire Inc. - 8/12/2021 4:05:00 PM
KemPharm to Report Second Quarter 2021 Results GlobeNewswire Inc. - 8/5/2021 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/21/2021 8:46:55 AM
gi197845   Wednesday, 08/04/21 02:47:52 PM
Re: doebop post# 754
Post # of 773 
Your logic might have worked before the shelf offering...
Remember how it went to $18 and then next day, back to $9...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences